{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T11:26:58Z","timestamp":1770463618175,"version":"3.49.0"},"reference-count":70,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004281","name":"Narodowe Centrum Nauki","doi-asserted-by":"publisher","award":["2017\/27\/B\/NZ7\/01633"],"award-info":[{"award-number":["2017\/27\/B\/NZ7\/01633"]}],"id":[{"id":"10.13039\/501100004281","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004281","name":"Narodowe Centrum Nauki","doi-asserted-by":"publisher","award":["2020\/37\/B\/NZ7\/02546"],"award-info":[{"award-number":["2020\/37\/B\/NZ7\/02546"]}],"id":[{"id":"10.13039\/501100004281","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicology and Applied Pharmacology"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1016\/j.taap.2022.116318","type":"journal-article","created":{"date-parts":[[2022,11,19]],"date-time":"2022-11-19T10:57:28Z","timestamp":1668855448000},"page":"116318","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["In silico and in vitro ADME-Tox analysis and in vivo pharmacokinetic study of representative pan-PDE inhibitors from the group of 7,8-disubstituted derivatives of 1,3-dimethyl-7H-purine-2,6-dione"],"prefix":"10.1016","volume":"457","author":[{"given":"Katarzyna","family":"W\u00f3jcik-Pszczo\u0142a","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ma\u0142gorzata","family":"Szafarz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Krzysztof","family":"Pociecha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karolina","family":"S\u0142oczy\u0144ska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kamil","family":"Piska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paulina","family":"Koczurkiewicz-Adamczyk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natalia","family":"Kocot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gra\u017cyna","family":"Ch\u0142o\u0144-Rzepa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"El\u017cbieta","family":"P\u0119kala","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"El\u017cbieta","family":"Wyska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.taap.2022.116318_bb0005","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1080\/17425255.2017.1389897","article-title":"In silico ADME-Tox modeling: progress and prospects","volume":"13","author":"Alqahtani","year":"2017","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"key":"10.1016\/j.taap.2022.116318_bb0010","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1210\/er.2013-1053","article-title":"Clinical and molecular genetics of the phosphodiesterases (PDEs)","volume":"35","author":"Azevedo","year":"2014","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.taap.2022.116318_bb0015","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1038\/s41573-019-0033-4","article-title":"Therapeutic targeting of 3\u2032,5\u2032-cyclic nucleotide phosphodiesterases: inhibition and beyond","volume":"18","author":"Baillie","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.taap.2022.116318_bb0020","doi-asserted-by":"crossref","first-page":"725","DOI":"10.3390\/ph3030725","article-title":"Theophylline","volume":"3","author":"Barnes","year":"2010","journal-title":"Pharmaceuticals (Basel)"},{"key":"10.1016\/j.taap.2022.116318_bb0025","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1164\/rccm.201302-0388PP","article-title":"Theophylline","volume":"188","author":"Barnes","year":"2013","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.taap.2022.116318_bb0030","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1164\/rccm.201301-0021PP","article-title":"Phosphodiesterase-4 inhibitor therapy for lung diseases","volume":"188","author":"Begh\u00e8","year":"2013","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.taap.2022.116318_bb0035","doi-asserted-by":"crossref","first-page":"5228","DOI":"10.1021\/acs.jpcb.7b02914","article-title":"Predicting a drug\u2019s membrane permeability: a computational model validated with in vitro permeability assay data","volume":"121","author":"Bennion","year":"2017","journal-title":"J. Phys. Chem. B"},{"issue":"5","key":"10.1016\/j.taap.2022.116318_bb0040","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1124\/dmd.108.026112","article-title":"Utility of MetaSite in improving metabolic stability of the neutral indomethacin amide derivative and selective cyclooxygenase-2 inhibitor 2-(1-(4-chlorobenzoyl)-5-methoxy-2-methyl-1H-indol-3-yl)-N-phenethyl-acetamide","volume":"37","author":"Boyer","year":"2009","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.taap.2022.116318_bb0045","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1111\/bcpt.12054","article-title":"Genotoxicity and carcinogenicity studies of bronchodilators and AntiAsthma drugs","volume":"112","author":"Brambilla","year":"2013","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"key":"10.1016\/j.taap.2022.116318_bb0050","doi-asserted-by":"crossref","first-page":"3197","DOI":"10.1111\/bcp.14735","article-title":"Effect of lipophilicity on drug distribution and elimination: influence of obesity","volume":"87","author":"Bruno","year":"2021","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.taap.2022.116318_bb0055","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1093\/toxsci\/kfu058","article-title":"Chromosome breakage induced by the genotoxic agents mitomycin C and cytosine arabinoside is concentration and p53 dependent","volume":"140","author":"Br\u00fcsehafer","year":"2014","journal-title":"Toxicol. Sci."},{"issue":"3","key":"10.1016\/j.taap.2022.116318_bb0060","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1007\/s11095-006-9199-7","article-title":"Predicting the oxidative metabolism of statins: an application of the MetaSite algorithm","volume":"24","author":"Caron","year":"2007","journal-title":"Pharm. Res."},{"key":"10.1016\/j.taap.2022.116318_bb0065","article-title":"Efficacy and safety profile of xanthines in COPD: a network meta-analysis","volume":"27","author":"Cazzola","year":"2018","journal-title":"Eur. Respir. Rev. Off. J. Eur. Respir. Soc."},{"key":"10.1016\/j.taap.2022.116318_bb0070","doi-asserted-by":"crossref","DOI":"10.1183\/16000617.0095-2019","article-title":"The future of bronchodilation: looking for new classes of bronchodilators","volume":"28","author":"Cazzola","year":"2019","journal-title":"Eur. Respir. Rev."},{"key":"10.1016\/j.taap.2022.116318_bb0075","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.ejmech.2018.01.068","article-title":"Novel butanehydrazide derivatives of purine-2,6-dione as dual PDE4\/7 inhibitors with potential anti-inflammatory activity: design, synthesis and biological evaluation","volume":"146","author":"Ch\u0142o\u0144-Rzepa","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.taap.2022.116318_bb0080","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.ejmech.2018.09.021","article-title":"Novel amide derivatives of 1,3-dimethyl-2,6-dioxopurin-7-yl-alkylcarboxylic acids as multifunctional TRPA1 antagonists and PDE4\/7 inhibitors: a new approach for the treatment of pain","volume":"158","author":"Ch\u0142o\u0144-Rzepa","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.taap.2022.116318_bb0085","article-title":"Phosphodiesterase 4 inhibitors for chronic obstructive pulmonary disease","volume":"9","author":"Chong","year":"2017","journal-title":"Cochrane Database Syst. Rev."},{"issue":"22","key":"10.1016\/j.taap.2022.116318_bb0090","doi-asserted-by":"crossref","first-page":"6970","DOI":"10.1021\/jm050529c","article-title":"MetaSite: understanding metabolism in human cytochromes from the perspective of the chemist","volume":"48","author":"Cruciani","year":"2005","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.taap.2022.116318_bb0095","doi-asserted-by":"crossref","first-page":"e155","DOI":"10.1016\/j.ddtec.2012.11.001","article-title":"Exposition and reactivity optimization to predict sites of metabolism in chemicals","volume":"10","author":"Cruciani","year":"2013","journal-title":"Drug Discov. Today Technol."},{"key":"10.1016\/j.taap.2022.116318_bb0100","doi-asserted-by":"crossref","first-page":"42717","DOI":"10.1038\/srep42717","article-title":"SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules","volume":"7","author":"Daina","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.taap.2022.116318_bb0105","doi-asserted-by":"crossref","first-page":"503","DOI":"10.2174\/1389200222666210705122913","article-title":"ADMET profiling in drug discovery and development: perspectives of in silico, in vitro and integrated approaches","volume":"22","author":"Daoud","year":"2021","journal-title":"Curr. Drug Metab."},{"key":"10.1016\/j.taap.2022.116318_bb0110","doi-asserted-by":"crossref","DOI":"10.1023\/A:1018943613122","article-title":"Physiological parameters in laboratory animals and humans","author":"Davies","year":"1993","journal-title":"Pharm. Res."},{"key":"10.1016\/j.taap.2022.116318_bb0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2020.e03811","article-title":"Genotoxicity assessment of saline extract from Pilosocereus gounellei (Cactaceae) and its chemopreventive effect against cyclophosphamide-induced DNA damage","volume":"6","author":"de Oliveira","year":"2020","journal-title":"Heliyon"},{"key":"10.1016\/j.taap.2022.116318_bb0120","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s11419-015-0287-4","article-title":"4-Methoxy-\u03b1-PVP: in silico prediction, metabolic stability, and metabolite identification by human hepatocyte incubation and high-resolution mass spectrometry","volume":"34","author":"Ellefsen","year":"2015","journal-title":"Forensic Toxicol."},{"issue":"6","key":"10.1016\/j.taap.2022.116318_bb0125","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1208\/s12248-016-9963-5","article-title":"Metabolism of carfentanil, an ultra-potent opioid, in human liver microsomes and human hepatocytes by high-resolution mass spectrometry","volume":"18","author":"Feasel","year":"2016","journal-title":"AAPS J."},{"key":"10.1016\/j.taap.2022.116318_bb0130","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1038\/nprot.2007.77","article-title":"Cytokinesis-block micronucleus cytome assay","volume":"2","author":"Fenech","year":"2007","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.taap.2022.116318_bb0135","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/0300-483X(93)90064-Y","article-title":"Biotransformation of methylxanthines in mammalian cell lines genetically engineered for expression of single cytochrome P450 isoforms. Allocation of metabolic pathways to isoforms and inhibitory effects of quinolones","volume":"82","author":"Fuhr","year":"1993","journal-title":"Toxicology"},{"key":"10.1016\/j.taap.2022.116318_bb0140","doi-asserted-by":"crossref","first-page":"265","DOI":"10.2147\/DDDT.S118485","article-title":"Theophylline action on primary human bronchial epithelial cells under proinflammatory stimuli and steroidal drugs: a therapeutic rationale approach","volume":"11","author":"Gallelli","year":"2017","journal-title":"Drug Des. Devel. Ther."},{"key":"10.1016\/j.taap.2022.116318_bb0145","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S1383-5718(99)00093-5","article-title":"Mutagenic and genotoxic effects of theophylline and theobromine in Salmonella assay and in vivo sister chromatid exchanges in bone marrow cells of mice","volume":"444","author":"Giri","year":"1999","journal-title":"Mutat. Res."},{"key":"10.1016\/j.taap.2022.116318_bb0150","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/BF00613930","article-title":"Non-linear elimination processes of theophylline","volume":"24","author":"Gundert-Remy","year":"1983","journal-title":"Eur. J. Clin. Pharmacol."},{"issue":"1","key":"10.1016\/j.taap.2022.116318_bb0155","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s41021-021-00206-1","article-title":"Bacterial mutagenicity test data: collection by the task force of the Japan pharmaceutical manufacturers association","volume":"43","author":"Hakura","year":"2021","journal-title":"Genes Environ."},{"key":"10.1016\/j.taap.2022.116318_bb0160","doi-asserted-by":"crossref","first-page":"295","DOI":"10.3109\/03602538308991392","article-title":"Metabolism and pharmacokinetics of theophylline in human neonates, children, and adults","volume":"14","author":"Haley","year":"1983","journal-title":"Drug Metab. Rev."},{"key":"10.1016\/j.taap.2022.116318_bb0165","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.pupt.2010.03.011","article-title":"The preclinical pharmacology of roflumilast \u2013 a selective, oral phosphodiesterase 4 inhibitor in development for chronic obstructive pulmonary disease","volume":"23","author":"Hatzelmann","year":"2010","journal-title":"Pulm. Pharmacol. Ther."},{"key":"10.1016\/j.taap.2022.116318_bb0170","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1111\/j.1476-5381.2010.01127.x","article-title":"Principles of early drug discovery","volume":"162","author":"Hughes","year":"2011","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.taap.2022.116318_bb0175","series-title":"Theophylline Toxicity. [WWW Document]","author":"Journey","year":"2022"},{"key":"10.1016\/j.taap.2022.116318_bb0180","doi-asserted-by":"crossref","first-page":"518345","DOI":"10.3389\/fphar.2021.518345","article-title":"Phosphodiesterase-4 inhibitors for non-COPD respiratory diseases","volume":"12","author":"Kawamatawong","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.taap.2022.116318_bb0185","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1046\/j.1440-1592.2003.00306.x","article-title":"Efficacy and safety of methylxanthines in the treatment of asthma","volume":"53","author":"Makino","year":"2004","journal-title":"Allergol. Int."},{"key":"10.1016\/j.taap.2022.116318_bb0190","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1007\/s12010-017-2527-z","article-title":"In vitro biotransformation, safety, and chemopreventive action of novel 8-Methoxy-Purine-2,6-Dione derivatives","volume":"184","author":"Mar\u0107","year":"2018","journal-title":"Appl. Biochem. Biotechnol."},{"key":"10.1016\/j.taap.2022.116318_bb0195","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1080\/15376510701857320","article-title":"In silico tools for sharing data and knowledge on toxicity and metabolism: derek for windows, meteor, and vitic","volume":"18","author":"Marchant","year":"2008","journal-title":"Toxicol. Mech. Methods"},{"key":"10.1016\/j.taap.2022.116318_bb0200","doi-asserted-by":"crossref","first-page":"2363","DOI":"10.2147\/COPD.S226688","article-title":"Inhaled dual phosphodiesterase 3\/4 inhibitors for the treatment of patients with COPD: a short review","volume":"16","author":"Martin","year":"2021","journal-title":"Int. J. Chron. Obstruct. Pulmon. Dis."},{"issue":"1","key":"10.1016\/j.taap.2022.116318_bb0205","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1089\/adt.2007.103","article-title":"An automated liquid chromatography-mass spectrometry process to determine metabolic stability half-life and intrinsic clearance of drug candidates by substrate depletion","volume":"6","author":"McNaney","year":"2008","journal-title":"Assay Drug Dev. Technol."},{"issue":"1\u20132","key":"10.1016\/j.taap.2022.116318_bb0210","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0027-5107(00)00064-6","article-title":"The Ames Salmonella\/microsome mutagenicity assay","volume":"455","author":"Mortelmans","year":"2000","journal-title":"Mutat. Res."},{"key":"10.1016\/j.taap.2022.116318_bb0215","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/978-3-642-13443-2_6","article-title":"Xanthines as adenosine receptor antagonists","author":"M\u00fcller","year":"2011","journal-title":"Handb. Exp. Pharmacol."},{"key":"10.1016\/j.taap.2022.116318_bb0220","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.rmed.2016.01.022","article-title":"The potential of methylxanthine-based therapies in pediatric respiratory tract diseases","volume":"112","author":"O\u00f1atibia-Astibia","year":"2016","journal-title":"Respir. Med."},{"key":"10.1016\/j.taap.2022.116318_bb0225","doi-asserted-by":"crossref","first-page":"1600670","DOI":"10.1002\/mnfr.201600670","article-title":"Health benefits of methylxanthines in neurodegenerative diseases","volume":"61","author":"O\u00f1atibia-Astibia","year":"2017","journal-title":"Mol. Nutr. Food Res."},{"key":"10.1016\/j.taap.2022.116318_bb0230","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1006\/phrs.2001.0831","article-title":"Toxicity of theophylline depends on plasma concentration by single and also repeated dosing in rats","volume":"44","author":"Onodera","year":"2001","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.taap.2022.116318_bb0235","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.coph.2012.02.016","article-title":"Selective PDE inhibitors as novel treatments for respiratory diseases","volume":"12","author":"Page","year":"2012","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.taap.2022.116318_bb0240","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1007\/s11095-015-1800-5","article-title":"Predicting mouse liver microsomal stability with \u201cpruned\u201d machine learning models and public data","volume":"33","author":"Perryman","year":"2016","journal-title":"Pharm. Res."},{"key":"10.1016\/j.taap.2022.116318_bb0245","doi-asserted-by":"crossref","first-page":"923","DOI":"10.18388\/abp.2005_3408","article-title":"Methylxanthines (caffeine, pentoxifylline and theophylline) decrease the mutagenic effect of daunomycin, doxorubicin and mitoxantrone","volume":"52","author":"Piosik","year":"2005","journal-title":"Acta Biochim. Pol."},{"key":"10.1016\/j.taap.2022.116318_bb0250","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1111\/j.2042-7158.1997.tb06749.x","article-title":"Effect of tamoxifen on the pharmacokinetics of theophylline in rats","volume":"49","author":"Poisson","year":"1997","journal-title":"J. Pharm. Pharmacol."},{"issue":"2","key":"10.1016\/j.taap.2022.116318_bb0255","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/BF03256599","article-title":"Targeting adenosine receptors: novel therapeutic targets in asthma and chronic obstructive pulmonary disease","volume":"1","author":"Rorke","year":"2002","journal-title":"Am. J. Respir. Med."},{"issue":"6","key":"10.1016\/j.taap.2022.116318_bb0260","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/0002-9343(90)90519-J","article-title":"Theophylline toxicity: clinical features of 116 consecutive cases","volume":"88","author":"Sessler","year":"1990","journal-title":"Am. J. Med."},{"key":"10.1016\/j.taap.2022.116318_bb0265","doi-asserted-by":"crossref","DOI":"10.4172\/2157-7609.1000126","article-title":"Comparative in-vitro intrinsic clearance of imipramine in multiple species liver microsomes: human, rat, mouse and dog","volume":"3","author":"Singh","year":"2012","journal-title":"J. Drug Metab. Toxicol."},{"key":"10.1016\/j.taap.2022.116318_bb0270","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1177\/026119299502300414","article-title":"Toxicity, clastogenicity and genotoxicity of theophylline and pentoxifylline in mammalian cells cultured in vitro","volume":"23","author":"Slame\u0148ov\u00e1","year":"1995","journal-title":"Altern. Lab. Anim"},{"key":"10.1016\/j.taap.2022.116318_bb0275","article-title":"Metabolic stability and its role in the discovery of new chemical entities","volume":"69","author":"S\u0142oczy\u0144ska","year":"2019","journal-title":"Acta Pharma."},{"issue":"15","key":"10.1016\/j.taap.2022.116318_bb0280","doi-asserted-by":"crossref","first-page":"3621","DOI":"10.1007\/s00216-014-7793-9","article-title":"Metabolism of JWH-015, JWH-098, JWH-251, and JWH-307 in silico and in vitro: a pilot study for the detection of unknown synthetic cannabinoids metabolites","volume":"406","author":"Strano-Rossi","year":"2014","journal-title":"Anal. Bioanal. Chem."},{"key":"10.1016\/j.taap.2022.116318_bb0285","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1016\/S0021-9258(19)77423-7","article-title":"Fractionation and characterization of a cyclic adenine ribonucleotide formed by tissue particles","volume":"232","author":"Sutherland","year":"1958","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.taap.2022.116318_bb0290","article-title":"The impact of CYP1A2 and CYP2E1 genes polymorphism on theophylline response","volume":"10","author":"Sutrisna","year":"2016","journal-title":"J. Clin. Diagn. Res."},{"key":"10.1016\/j.taap.2022.116318_bb0295","doi-asserted-by":"crossref","first-page":"165","DOI":"10.3109\/00498258509045346","article-title":"Dose-dependent elimination of theophylline in rats","volume":"15","author":"Teunissen","year":"1985","journal-title":"Xenobiotica"},{"key":"10.1016\/j.taap.2022.116318_bb0300","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/978-3-642-13443-2_17","article-title":"Methylxanthines in asthma","author":"Tilley","year":"2011","journal-title":"Handb. Exp. Pharmacol."},{"issue":"11","key":"10.1016\/j.taap.2022.116318_bb0305","doi-asserted-by":"crossref","first-page":"2066","DOI":"10.1124\/dmd.111.039982","article-title":"Evaluation of three state-of-the-art metabolite prediction software packages (Meteor, MetaSite, and StarDrop) through independent and synergistic use","volume":"39","author":"T'jollyn","year":"2011","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.taap.2022.116318_bb0310","doi-asserted-by":"crossref","DOI":"10.1016\/j.mrgentox.2019.503081","article-title":"Are all bacterial strains required by OECD mutagenicity test guideline TG471 needed?","volume":"848","author":"Williams","year":"2019","journal-title":"Mutat. Res. Genet. Toxicol. Environ. Mutagen."},{"issue":"8","key":"10.1016\/j.taap.2022.116318_bb0315","first-page":"779","article-title":"Metabolic characterization of AH-7921, a synthetic opioid designer drug: in vitro metabolic stability assessment and metabolite identification, evaluation of in silico prediction, and in vivo confirmation drug test","volume":"8","author":"Wohlfarth","year":"2016","journal-title":"Anal."},{"key":"10.1016\/j.taap.2022.116318_bb0320","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2019.172779","article-title":"Novel phosphodiesterases inhibitors from the group of purine-2,6-dione derivatives as potent modulators of airway smooth muscle cell remodelling","volume":"865","author":"W\u00f3jcik-Pszczo\u0142a","year":"2019","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.taap.2022.116318_bb0325","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21114008","article-title":"A novel, Pan-PDE inhibitor exerts anti-fibrotic effects in human lung fibroblasts via inhibition of TGF-\u03b2 signaling and activation of cAMP\/PKA signaling","volume":"21","author":"W\u00f3jcik-Pszczo\u0142a","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.taap.2022.116318_bb0330","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2021.105409","article-title":"Synthesis and in vitro evaluation of anti-inflammatory, antioxidant, and anti-fibrotic effects of new 8-aminopurine-2,6-dione-based phosphodiesterase inhibitors as promising anti-asthmatic agents","volume":"117","author":"W\u00f3jcik-Pszczo\u0142a","year":"2021","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.taap.2022.116318_bb0335","doi-asserted-by":"crossref","DOI":"10.3390\/ph15040423","article-title":"Pan-phosphodiesterase inhibitors attenuate TGF-\u03b2-induced pro-fibrotic phenotype in alveolar epithelial type II cells by downregulating Smad-2 phosphorylation","volume":"15","author":"W\u00f3jcik-Pszczo\u0142a","year":"2022","journal-title":"Pharmaceuticals (Basel)"},{"key":"10.1016\/j.taap.2022.116318_bb0340","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/j.apsb.2018.04.003","article-title":"Drug metabolism in drug discovery and development","volume":"8","author":"Zhang","year":"2018","journal-title":"Acta Pharm. Sin. B"},{"issue":"6","key":"10.1016\/j.taap.2022.116318_bb0345","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1124\/dmd.105.008631","article-title":"Comparison of methods for the prediction of the metabolic sites for CYP3A4-mediated metabolic reactions","volume":"34","author":"Zhou","year":"2006","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.taap.2022.116318_bb0350","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.pharmthera.2019.02.002","article-title":"Phosphodiesterases as therapeutic targets for respiratory diseases","volume":"197","author":"Zuo","year":"2019","journal-title":"Pharmacol. Ther."}],"container-title":["Toxicology and Applied Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041008X2200463X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041008X2200463X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T21:01:50Z","timestamp":1758574910000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041008X2200463X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":70,"alternative-id":["S0041008X2200463X"],"URL":"https:\/\/doi.org\/10.1016\/j.taap.2022.116318","relation":{},"ISSN":["0041-008X"],"issn-type":[{"value":"0041-008X","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"In silico and in vitro ADME-Tox analysis and in vivo pharmacokinetic study of representative pan-PDE inhibitors from the group of 7,8-disubstituted derivatives of 1,3-dimethyl-7H-purine-2,6-dione","name":"articletitle","label":"Article Title"},{"value":"Toxicology and Applied Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.taap.2022.116318","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"116318"}}